ストックスクリーナーアプリを入手
22.64
0.66%
-0.15
前日終値:
$22.79
開ける：
$22.57
24時間の取引高:
648.94K
Relative Volume:
0.84
時価総額：
$1.60B
収益：
$80.89M
当期純損益:
$-144.73M
株価収益率:
-7.6229
EPS:
-2.97
ネットキャッシュフロー:
$-83.87M
1週間 パフォーマンス:
-16.61%
1か月 パフォーマンス:
-9.62%
6か月 パフォーマンス:
+39.84%
1年 パフォーマンス:
+247.77%
1日の値動き範囲:
$21.88
$22.88
1週間の範囲:
$20.65
$27.53
52週間の値動き範囲:
$5.65
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
名前
Nurix Therapeutics Inc
セクター
電話
(415) 660-5320
住所
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| NRIX | 22.64 | 1.60B | 80.89M | -144.73M | -83.87M | -2.97 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-31 | 開始されました | Truist | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-03-09 | 開始されました | Barclays | Overweight |
| 2023-02-28 | 開始されました | Oppenheimer | Outperform |
| 2022-10-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 開始されました | Wells Fargo | Equal Weight |
| 2021-12-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-30 | 再開されました | Piper Sandler | Overweight |
| 2021-04-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-11-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | Stifel | Buy |
すべてを表示
Nurix Therapeutics Inc (NRIX) 最新ニュース
Nurix Therapeutics Receives PRIME Designation from the - GlobeNewswire
Nurix's Cancer Drug NX-5948 Secures EMA PRIME Status for Advanced Leukemia Treatment | NRIX Stock News - StockTitan
Amalgamated Bank Has $49,000 Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap DownShould You Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases New Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Chevron Corp (CVX-N) QuotePress Release - The Globe and Mail
Mplx LP (MPLX-N) QuotePress Release - The Globe and Mail
Nurix Therapeutics Presents Preclinical Data from Two - GlobeNewswire
Nurix Reports Strong Preclinical Data for Two Novel Autoimmune Disease Treatments | NRIX Stock News - StockTitan
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 8.7%Should You Sell? - MarketBeat
Redmile Group, LLC Expands Stake in Nurix Therapeutics Inc - GuruFocus.com
Significant Stake Increase by Baker Bros. Advisors in Nurix Ther - GuruFocus.com
WASATCH ADVISORS LP Adjusts Stake in Nurix Therapeutics Inc - GuruFocus.com
When the Price of (NRIX) Talks, People Listen - Stock Traders Daily
Conocophillips (COP-N) QuotePress Release - The Globe and Mail
Wellington Management Group LLP Increases Stake in Nurix Therape - GuruFocus.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Purchased by International Assets Investment Management LLC - Defense World
ARK Investment Management LLC Has $49.80 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics stock soars to 52-week high of $27.61 By Investing.com - Investing.com Canada
Morgan Stanley's Strategic Reduction in Nurix Therapeutics Holdi - GuruFocus.com
Nurix Therapeutics (NASDAQ:NRIX) Hits New 1-Year HighHere's Why - MarketBeat
Nurix Therapeutics stock soars to 52-week high of $27.61 - Investing.com India
Subdued Growth No Barrier To Nurix Therapeutics, Inc. (NASDAQ:NRIX) With Shares Advancing 25% - Simply Wall St
Cisco Systems Inc (CSCO-Q) QuotePress Release - The Globe and Mail
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts - Benzinga
Nurix Therapeutics' (NRIX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire
Nurix therapeutics' chief legal officer sells $82,250 in stock - Investing.com India
SEC Form 424B5 filed by Nurix Therapeutics Inc. - Quantisnow
Nurix therapeutics' chief legal officer sells $82,250 in stock By Investing.com - Investing.com UK
(NRIX) Technical Pivots with Risk Controls - Stock Traders Daily
Nurix therapeutics CFO Hans van Houte sells $86,083 in stock - Investing.com India
Houte Hans Van Sells 3,546 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock - MarketBeat
Nurix therapeutics CFO Hans van Houte sells $86,083 in stock By Investing.com - Investing.com Australia
Nurix therapeutics chief legal officer sells $139,866 in stock By Investing.com - Investing.com South Africa
Nurix therapeutics chief legal officer sells $139,866 in stock - Investing.com India
Insider Sale: CFO Houte Van Sells Shares of Nurix Therapeutics I - GuruFocus.com
Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Companies Like Nurix Therapeutics (NASDAQ:NRIX) Are In A Position To Invest In Growth - Simply Wall St
Nurix therapeutics chief scientific officer sells shares worth $83,536 By Investing.com - Investing.com Australia
Nurix therapeutics chief legal officer sells shares worth over $101k By Investing.com - Investing.com South Africa
Nurix therapeutics chief scientific officer sells shares worth $83,536 - Investing.com
Nurix therapeutics chief legal officer sells shares worth over $101k - Investing.com
Nurix therapeutics CFO Hans van Houte sells $57,554 in stock - Investing.com
Nurix therapeutics CFO Hans van Houte sells $57,554 in stock By Investing.com - Investing.com Australia
Allspring Global Investments Holdings LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Allspring Global Investments Holdings LLC Makes New $3.15 Million Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Magna International Inc (MG-T) QuotePress Release - The Globe and Mail
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics stock soars to 52-week high of $26.46 By Investing.com - Investing.com Canada
Nurix Therapeutics (NASDAQ:NRIX) Now Covered by UBS Group - Defense World
Nurix Therapeutics Inc (NRIX) 財務データ
収益
当期純利益
現金流量
EPS
0.69%
6.90%
大文字化:
|
ボリューム (24 時間):